#Germany In Vitro Fertilization (IVF) Market news
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
If you dial 1-866-584-6757, you can leave an audio post for your followers.
Text
In Vitro Fertilization (IVF) Market Strategies: Navigating Challenges for Success till 2031
Industry Overview of In Vitro Fertilization (IVF) Market
Straits Research has added a new report titled, “Global In Vitro Fertilization (IVF) Market Market Professional Report 2031” to its vast repository of research reports. This is a comprehensive report focused on the current and prospects of the Global In Vitro Fertilization (IVF) Market Market. The report also mentions the impact of the coronavirus pandemic on the market. Furthermore, the study includes the steps the leading industry players have taken to recover the losses (if any).
The global In vitro fertilization (IVF) market size is growing at a CAGR of 6.2% during the forecast period (2023–2031).
The report on the Global In Vitro Fertilization (IVF) Market Market offers data from previous years along with an in-depth analysis from 2023 to 2031 based on revenue (USD Billion). Besides, the report offers a comprehensive analysis of the factors driving and restraining the growth of the market coupled with the impact they have on the demand over the forecast period.
Request Sample Report of Global In Vitro Fertilization (IVF) Market Market @ https://straitsresearch.com/report/in-vitro-fertilization-market/request-sample
OvaScience
EMD Serono Inc.
Vitrolife AB
Irvine Scientific
Cook Medical Inc.
Cooper Surgical Inc.
Genea Biomedx
Thermo Fisher Scientific Inc.
Progyny, Inc.
Boston IVF
The market is segmented into different sections such as: by product type, by technology type, by application, by end-users, by deployment mode, and by key geography. The report then employs market breakdown and data triangulation procedures to complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments. The report on the Global In Vitro Fertilization (IVF) Market Market has been curated by analyzing the top players functioning in the market. In order to get an in-depth analysis of the market, the report carried out a SWOT analysis, Porter’s five forces analysis, and Pestel analysis.
Market Segmentation:
By Type, Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor
By End-use, Fertility Clinics, Hospitals
By Instrument, Culture Media, Disposable Devices, Capital Equipment
This report forecasts revenue growth at the global, regional, and local levels and provides an analysis of the most recent industry trends from 2023 to 2031 in each of the segments and sub-segments. In addition, the report highlights the impact of COVID-19 on the Global In Vitro Fertilization (IVF) Market Market and how the market is undertaking measures to reduce the losses. Some of the major geographies included in the market are given below:
North America(S., Canada)
Europe(K., Germany, France, Italy)
Asia Pacific(China, India, Japan, Singapore, Malaysia)
Latin America(Brazil, Mexico)
Middle East & Africa
Buy Now: https://straitsresearch.com/buy-now/in-vitro-fertilization-market
Key Questions Answered in the Report:
What is the current scenario of the Global In Vitro Fertilization (IVF) Market Market?
How is the market going to prosper throughout the next 6 years?
What are the emerging technologies that are going to profit the market?
What are the historical and current sizes of the Global In Vitro Fertilization (IVF) Market Market?
Which segments are the fastest growing and the largest in the market? What is their market potential?
What are the driving factors contributing to the market growth during the short, medium, and long term? What are the major challenges and shortcomings that the market is likely to face? How can the market solve the challenges?
What are the major strategies adopted by the leading players to expand their market shares?
Latest Updated Reports
https://justpaste.it/wine-industry
Contact Us
Email: [email protected] Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
About Straits Research
Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.
0 notes
Text
Assisted Reproductive Technologies (ART) Market Share, Size - Verified Industry Insights
Our Verified Industry Insights report on the Global Assisted Reproductive Technologies (ART) Market is an invaluable source of information for stakeholders in the market. Our report provides an in-depth analysis of the current market outlook, opportunities, and trends and also offers a comprehensive overview of the market including historical data, market size, and forecast as well. It also provides an overview of the major market players in the market and their competitive landscape.
Assisted Reproductive Technologies (ART) Market was valued at USD 3234.69 Million in 2022 and is projected to reach USD 12, 272.05 Million by 2030, growing at a CAGR of 18.14 % from 2023 to 2030.
The report also offers an in-depth analysis of the latest industry developments, such as new product launches, mergers & acquisitions, strategic collaborations, and partnerships with other market players. Furthermore, the report also provides an inside look at the competitive landscape and a detailed assessment of the market segments to help stakeholders make informed decisions. Additionally, the report offers insights into the industry dynamics which can help readers to understand the forces acting upon the market and the factors driving its growth. With the help of this report, our readers can gain comprehensive and reliable insights into the Global Assisted Reproductive Technologies (ART) Market.
Get a Sample PDF copy of this Assisted Reproductive Technologies (ART) Market Report:
Assisted Reproductive Technologies (ART) Market report also includes a pricing analysis for each type, manufacturer, region, and global price from 2018 to 2030. This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth.
This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.
Major Players Covered in this Report are:
Cooper Surgical Hamilton Thorne, Inc. (U.S.) Ferring B.V.,(U.S.) FUJIFILM Irvine Scientific, Inc.,(U.S.) Laboratoire, Nidacon International AB, (Sweden), Ova Science Inc.,(U.K.) Vitrolife (Sweden), Memmert GmbH + Co.KG (Germany), Genea Biomedex (U.K), Nividia (U.S.), Progyny (U.S.), and Others.
One of the important sections of the research study includes the company profiling of key figures of the Assisted Reproductive Technologies (ART) Market. The authors of the report closely analyze all of the leading companies considered for the research study on the basis of different factors such as their main business, gross margin, and markets served. They also consider their prices, revenue, and production apart from the specification and application of their products. The review period considered here is of nine years.
Global Assisted Reproductive Technologies (ART) Market Segmentation Analysis
The outbreak of COVID-19 has dramatically changed the Assisted Reproductive Technologies (ART) Market. Worldwide, the industry saw signs of recovery in the second quarter, but the industry remains concerned about the prospects of long-term recovery as COVID-19 cases continue to rise, especially in Asian countries such as India.
Assisted Reproductive Technologies (ART) Market, By Technology
In-Vitro Fertilization (IVF)
Artificial Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Surrogacy
Ovulation Induction
Others
Assisted Reproductive Technologies (ART) Market, By End-user
Hospitals
Fertility Clinics
Clinical Research
Others
Since the start of the pandemic, the industry received a series of blows and surprises. The pandemic has also led to many changes in buyer behavior and attitude. Thus, it is putting additional stress on the industry. This, in turn, is expected to restrain the growth of the market.
Some of the Key Questions Answered in this Report:
What is the Assisted Reproductive Technologies (ART) Market size at the regional and country-level
What are the key drivers, restraints, opportunities, and challenges of the Assisted Reproductive Technologies (ART) Market , and how they are expected to impact the market
What is the global (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) sales value, production value, consumption value, import and export of Assisted Reproductive Technologies (ART) Market
Who are the global key manufacturers of the Assisted Reproductive Technologies (ART) Market? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)
What are the Assisted Reproductive Technologies (ART) Market opportunities and threats faced by the vendors in the Assisted Reproductive Technologies (ART) Market?
Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
What focused approach and constraints are holding the Assisted Reproductive Technologies (ART) Market?
What are the different sales, marketing, and distribution channels in the global industry?
What are the key market trends impacting the growth of Assisted Reproductive Technologies (ART) Market ?
Economic Impact on the Assisted Reproductive Technologies (ART) Market and development trend of the Assisted Reproductive Technologies (ART) Market
What are the Assisted Reproductive Technologies (ART) Market opportunities, market risk, and market overview of the Atorvastatin Calcium market
Each chapter of the report provides detailed information for readers to understand the Assisted Reproductive Technologies (ART) Market further:
Chapter 1: Assisted Reproductive Technologies (ART) Market Product Definition, Product Types, Volume, and Revenue Analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa from 2023 to 2030. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers' commercial date of Assisted Reproductive Technologies (ART) Market, product type offered by each manufacturer, Mergers & Acquisitions activities, and Expansion activities that occurred in the Assisted Reproductive Technologies (ART) Market. Chapter 3: Assisted Reproductive Technologies (ART) Market Historical (2023-2030) and Forecast (2023-2030) Volume and revenue analysis of Assisted Reproductive Technologies (ART) Market in North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Chapter 4: Assisted Reproductive Technologies (ART) Market Product Application, Volume, and Revenue Analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa from 2023 to 2030. Chapter 5 to 9: Assisted Reproductive Technologies (ART) Market Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa, including volume and revenue analysis. Chapter 10: Manufacturers' Outline, covering the company's basic information like headquarter, contact information, major business, Assisted Reproductive Technologies (ART) Market introduction, etc. Assisted Reproductive Technologies (ART) Market Sales, Revenue, Price, and Gross Margin of each company, as well as Recent Developments, are also contained in this part. Chapter 11: Industry chains, like raw materials, and manufacturing costs, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channels, Distributors, and Customers are listed. Chapter 13: Verified Market Reports Conclusions of Assisted Reproductive Technologies (ART) Market based on comprehensive survey. Chapter 14: Methodology and Data Sources.
About Us: Verified Industry Insights
Verified Industry Insights is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies.
We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Our research spans a multitude of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages, etc. Having serviced many Fortune 2000 organizations, we bring a rich and reliable experience covering all research needs.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080 US Toll-Free: +1 (800)-782-1768
0 notes
Text
Infertility Treatment Market Size, Share | 2026 | MarketsandMarkets
According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.
The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years
The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112
COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.
The rise in number of fertility clinics to support the market growth during the forecast period.
Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112
Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally
Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.
Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US).
1 note
·
View note
Text
In-vitro Fertilization Microscopes Market Growth Prospects And Industry Growth Rate 2022-2030
The rising prevalence of infertility among men and women is expected to foster the growth of the market for IVF microscopes during the forecast period.
The global in-vitro fertilization microscopes market size is expected to reach USD 193.2 million by 2030, according to a new report by Grand View Research. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. The market has witnessed advancements in microscopes and microscope-related equipment for use in in-vitro fertilization. Artificial Intelligence (AI), embryo assessment, and sperm selection are some of the applications targeted for innovation.
Manufacturers are providing upright microscopes, digital microscope cameras, and software to view images together as a sperm analysis system to provide the complete solution for semen analysis. Moreover, as sperm analysis can be better studied by maintaining a certain temperature of the sample, manufacturers are coupling the use of such devices along with an upright microscope. For instance, PROiSER provides ISAS HEAT, a slide warmer, compatible with its UB200i upright microscope used along with Computer Assisted Semen Analysis (CASA) systems.
The demand for In-vitro Fertilization (IVF) procedures is now increasing due to the relaxation of travel restrictions and supporting government guidelines. For instance, the American Society of Reproductive Medicine (ASRM) announced that there is a need to ensure reproductive care with maximal safety as we will have to continue to live with a COVID-19.
In-vitro Fertilization Microscopes Market Report Highlights
• Based on the end-use, the clinical segment dominated the market in 2021 in terms of revenue. IVF clinics provide a range of services, including healthy oocyte identification, semen analysis, ICSI, embryo monitoring, and freezing and storage of embryos
• The clinical segment is also expected to witness the fastest growth from 2022 to 2030 due to the increasing adoption of IVF treatment. Moreover, manufacturers are developing innovative products with integrated technologies, such as Artificial Intelligence (AI)
• Europe held the largest share in terms of revenue in 2021 due to factors such as the high cost of IVF treatment and the availability of reimbursement. The Asia Pacific region is expected to witness the fastest growth from 2022 to 2030 due to the initiatives to create awareness regarding IVF treatment in countries such as India
• The IVF microscopes market is saturated with many prominent players. The companies operating in the market are adopting various strategies such as product innovation, market expansion, and introduction of advanced technology to stay competitive in the market
• For instance, in February 2019, Opto GmbH debuted the DualStation embryo imaging microscope. The DualStation is designed to provide all the optical techniques and imaging requirements used by IVF processes into a single enclosed embryo chamber
The global life science microscopes industry generated over USD 3.36 billion in 2021 and is expected to grow at a CAGR of 8.9% over the forecast period.
In-vitro Fertilization Microscopes Market Segmentation
Grand View Research has segmented the global in-vitro fertilization microscopes market on the basis of end-use and region:
In-vitro Fertilization Microscopes End-use Outlook (Revenue, USD Million, 2017 – 2030)
• Clinical
• Academic Research
In-vitro Fertilization Microscopes Regional Outlook (Revenue, USD Million, 2017 – 2030)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
• Asia Pacific
o Japan
o China
o India
• Latin America
o Brazil
o Mexico
• Middle East & Africa (MEA)
o South Africa
List of Key Players in the In-vitro Fertilization Microscopes Market
• Linkam Scientific Instruments
• Olympus Corporation
• Leica Microsystems
• Meiji Techno
• Zeiss
• Euromex Microscopen B.V.
• Labomed Europe B.V.
• Nikon Corporation
• Narishige Group
• Eppendorf AG
• Hamilton Thorne Ltd.
• Sutter Instrument Company
• Tritech Research, Inc.
Request free sample copy of Life Science Microscopes Industry Data Book @ https://www.grandviewresearch.com/sector-report/life-science-microscopes-industry-data-book/request/rs
#In-vitro Fertilization Microscopes Market#In-vitro Fertilization Microscopes Market size#In-vitro Fertilization Microscopes Market share#In-vitro Fertilization Microscopes Market analysis
0 notes
Text
UK In Vitro Fertilization (IVF) Market 2021 Key Players, SWOT Analysis, Key Indicators and Forecast to 2031
The global market size of UK In Vitro Fertilization (IVF) Market is $XX million in 2020 with XX CAGR from 2015 to 2021, and it is expected to reach $XX million by the end of with a CAGR of XX% from.
Global UK In Vitro Fertilization (IVF) Market Report 2020 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global UK In Vitro Fertilization (IVF) Market industry. The key insights of the report:
1.The report provides key statistics on the market status of the UK In Vitro Fertilization (IVF) Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. 2.The report provides a basic overview of the industry including its definition, applications and manufacturing technology. 3.The report presents the company profile, product specifications, capacity, production value, and 2015-2020 market shares for key vendors. 4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. 5.The report estimates 2019-2024 market development trends of Bullet Train or High Speed Rail industry. 6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out 7.The report makes some important proposals for a new project of Bullet Train or High Speed Rail Industry before evaluating its feasibility.
Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/13250
There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.
KEY MARKET SEGMENTS UK In Vitro Fertilization Market
By Cycle Type o Fresh IVF Cycles (non-donor) o Thawed IVF Cycles (non-donor) o Donor Egg IVF Cycles
By End User o Fertility Clinics o Hospitals o Surgical Centers o Clinical Research Institutes
LIST of KEY PLAYERS PRofILED IN THE REPORT • The Lister Fertility Clinic • The Bridge Centre • Chelsea and Westminster Hospital (Assisted Conception Unit)
For competitor segment, the report includes global key players of UK In Vitro Fertilization (IVF) Market as well as some small players.
The information for each competitor includes: * Company Profile * Main Business Information * SWOT Analysis * Sales, Revenue, Price and Gross Margin * Market Share
For product type segment, this report listed main product type of UK In Vitro Fertilization (IVF) Market * Type I * Product Type II * Product Type III
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed. * Application I * Application II * Application III
For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions: * North America * South America * Asia & Pacific * Europe * MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc
Reasons to Purchase this Report:
Direct Purchase this Market Research Report Now @ https://www.trendsmarketresearch.com/checkout/13250/Single
* Analyzing the outlook of the market with the recent trends and SWOT analysis * Market dynamics scenario, along with growth opportunities of the market in the years to come * Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects * Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market. * Market value (USD Million) and volume (Units Million) data for each segment and sub-segment * Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years * Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
The research report of the global UK In Vitro Fertilization (IVF) Market Market provides answers to the following key questions:
• What is the expected market size, share, and CAGR of the UK In Vitro Fertilization (IVF) Market report by the end of the forecast period of 2030? • Does the report give customized insights on market segmentation as well as the intended audience? • What are the prime market growth driving factors and threats responsible for setting up the development of the UK In Vitro Fertilization (IVF) Market worldwide? • What are the prominent market players operating in the UK In Vitro Fertilization (IVF) Market? What strategies are adopted by them to stay ahead in the market? • What are the emerging and evolving technologies shaping the growth of the global market across various regions? • What are the opportunities in store of the business owners in the years to come?
Get Up to 10 % Discount on single User @ https://www.trendsmarketresearch.com/report/discount/13250
0 notes
Text
In Vitro Fertilization Market worth $987 million by 2026
According to the new market research report "In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecast to 2026", published by MarketsandMarkets™, the global In Vitro Fertilization Market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026.
The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891
The in vitro fertilization (IVF) market include major Tier I and II suppliers of in vitro fertilization equipment, reagents and media are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.
COVID-19 has impacted their businesses as well. COVID-19 pandemic triggered the worldwide suspension of in vitro fertilization treatment; this had a profound impact on women in the 40-42 age group, resulting in 11.8% reduction in live births due to a six-month delay in IVF treatment and a 22.4% reduction due to a 12-month delay in treatment in UK. In India, 30 lakh people seek IVF every year, but only 5 lakh people undergo IVF procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who had opted for IVF treatment before the pandemic
The rise in number of IVF with ICSI procedure to support the market growth during the forecast period.
The success rate of fertilization with ICSI procedure and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period. Moreover, the growing focus of players in expanding their product offerings in ICSI is anticipated to contribute towards the rapid adoption of IVF with ICSI procedures during the forecast period.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89198891
Asia Pacific likely to emerge as the fastest-growing in vitro fertilization market, globally.
Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 10.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the in vitro fertilization market in the region.
Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others
0 notes
Text
Preimplantation genetic testing Market Share, Industry Growth, Trend, Drivers, Challenges, Key Companies by 2026
Rising incidence single gene, mitochondrial, and other gene-related disorders, number of supportive initiatives adopted by the government authorities to promote reproductive health are key factors contributing to high CAGR of Preimplantation genetic testing during the forecast period.
the global Preimplantation genetic testing market was valued at USD 347.7 million in 2018 and is expected to reach USD 762.6 million by the year 2026, at a CAGR of 10.1%. Preimplantation Genetic testing identifies genetic defects in embryos, which are developed through Vitro Fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) is made when one or both the hereditary parents have a known hereditary disorder, and testing is performed on the embryo to determine whether it carries the same hereditary disorder. It is used is growing due to; increasing number of cases related to the predominance of genetic, hereditary and chromosomal diseases, rising knowledge amongst the population about the avoidance of genetic disorders.
A growing number of people suffering from genetic diseases are expected to increase demand for preimplantation genetic testing procedures to have a healthy child. Due to high pregnancy chances with the preimplantation genetic testing procedure as compared to other fertility treatments, the demand for PGI testing is expected to witness high demand among people seeking IVF treatments. Increasing applications for preimplantation genetic testing for the diagnosis of diseases like cancer and other minor disabilities like deafness is expected to create high growth opportunities for preimplantation genetic testing market stakeholders. Stringent government regulations related to the use of PGD have hindered the market growth of PGD market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2244
The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data. It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans. It also studies recent mergers and acquisitions, joint ventures, product launches, partnerships, collaborations, and agreements among other. The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.
Key Manufacturers in the Global Preimplantation Genetic Testing Market:
PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2244
The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions. It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region. The report also offer a country-wise analysis to impart a better understanding of the revenue growth of the market in each region.
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, France, Rest of Europe)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Test Type (Revenue, USD Million; 2016–2026)
Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Screening (PGS)
Type (Revenue, USD Million; 2016–2026)
Fresh Embryo (Own Eggs)
Frozen Embryo (Own Eggs)
Fresh Embryo (Donor Eggs)
Frozen Embryo (Donor Eggs)
Application (Revenue, USD Million; 2016–2026)
Embryo HLA Typing for Stem Cell Therapy
IVF Prognosis
Late Onset Genetic Disorders
Inherited Genetic Disease
Others
End Use (Revenue, USD Million; 2016–2026)
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
To know more about the report @ https://www.reportsanddata.com/report-detail/preimplantation-genetic-testing-market
Key Questions Addressed in the Report:
What is the market size the global Preimplantation Genetic Testing market is expected to reach over the forecast period? What is the expected CAGR?
What are the key segments of the market?
What are the key products and applications of the Preimplantation Genetic Testing market?
What factors are expected to drive and restrain market growth over the forecast period?
What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2244
Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more and our team will ensure the report is well suited to meet your requirements.
Browse more related reports:
Surgical Devices Market @ https://www.medgadget.com/2021/10/surgical-devices-market-growth-driven-by-increasing-need-to-treat-chronic-diseases-worldwide-reports-and-data.html
Nanomedicine Market @ https://www.medgadget.com/2021/10/nanomedicine-market-growth-driven-by-increasing-need-to-treat-chronic-and-infectious-diseases-worldwide-reports-and-data.html
BCG Vaccine Market @ https://www.medgadget.com/2021/10/bcg-vaccine-market-growth-driven-by-growing-demand-for-bacillus-calmette%e2%80%90guerin-bcg-vaccine-for-prevention-of-tuberculosis-reports-and-data.html
Bioreactors and Fermenters Market @ https://www.medgadget.com/2021/10/bioreactors-and-fermenters-market-growth-driven-by-increasing-biopharmaceutical-applications-of-bioreactors-and-fermenters-reports-and-data.html
Digital Radiography Market @ https://www.medgadget.com/2021/10/digital-radiography-market-growth-driven-by-rapid-digitization-in-the-healthcare-sector-reports-and-data.html
0 notes
Text
The global mammalian transient protein expressions market is estimated to reach a valuation of approximately US$ 540 million in 2020
A recent market study published by Future Market Insights on the Mammalian Transient Protein Expression market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics and Covid-19 crisis impact analysis. After conducting a thorough research on the historical as well as current growth parameters of the market, the growth prospects of the market are obtained with maximum precision.
Mammalian Transient Protein Expression Market: Segmentation
The Mammalian Transient Protein Expression market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Product Type
Instruments
Expression Vector
Reagents & Consumables
Cell Lines
Chinese Hamster Ovary Cells
Human Embryonic Kidney Cells
Others
Application
Bio Production
Functional Cell Based Assays
Academic Research
Others
Antibody Production
Therapeutic Protein Production
End User
Contract Research Organization
Biopharmaceutical Companies
Academic & Research Institutes
Region
North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, and Rest of Latin America)
Europe (Germany, Switzerland, France, UK, Rest of Europe)
East Asia (China, Japan, South Korea)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
Oceania (Australia and New Zealand)
Middle East & Africa (GCC Countries, Turkey, South Africa, Rest of MEA)
Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12807
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the Mammalian Transient Protein Expression market, which includes a summary of key findings and statistics of the market. It also includes supply-side and demand-side trends pertaining to the Mammalian Transient Protein Expression market.
Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the Mammalian Transient Protein Expression market in this chapter, which will help them understand the basic information about the Mammalian Transient Protein Expression market. Along with this, comprehensive information pertaining to Mammalian Transient Protein Expression and their features are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the Mammalian Transient Protein Expression market report.
Chapter 03 – Key Market Trends
Mammalian Transient Protein Expression market report provides the key market trends that are expected to significantly impact market growth during the forecast period. Detailed industry trends are provided in this section.
Chapter 04 – Key Success Factors
This section includes detailed analysis of Mammalian Transient Protein Expression products usage analysis, promotional strategies, pipeline assessment and regulatory and reimbursement scenario
Chapter 05 – Market Background
This chapter includes drivers and restraints of the Mammalian Transient Protein Expression market. This section also includes macroeconomic factors, and various opportunities of the Mammalian Transient Protein Expression market.
Chapter 06 – COVID-19 Crisis analysis
This section explains COVID-19 impact on the market, forecast factors, and economic impact.
Chapter 07 – Cost Analysis
This section explains production cost of mammalian transient protein expression using various cell lines.
Chapter 08 – Global Mammalian Transient Protein Expression Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
This section explains the global market value analysis and forecast for the Mammalian Transient Protein Expression market during the forecast period. This chapter includes a detailed analysis of the historical Mammalian Transient Protein Expression market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030)
Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12807
Why Future Market Insights?
Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the Radiometric Detectors market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Visit More Healthcare Reports:
U.S. Compounding Pharmacies Market: Compounding Pharmacies Market: U.S. Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028
Vision Screeners Market: Vision Screeners Market: R&D Innovations to Overcome Pediatric Vision Screening Challenges Trending: Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029
Donor Egg IVF (In-Vitro Fertilization) Market: Donor Egg IVF (In-Vitro Fertilization) Market: Government Funding & Reimbursement Policies to Play Instrumental Role: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 -2028
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
0 notes
Text
Preimplantation Genetic Testing Market Expected To Have A $107.3 Million Valuation By 2024
The global preimplantation genetic testing market is expected to reach USD 107.3 million by 2024, at a CAGR of 6.2% over the forecast period, according to a new report by Grand View Research, Inc. It is primarily driven by a rising awareness among couples to undergo diagnostic and screening tests to minimize genetic diseases and aneuploidy in fetus. The ability of preimplantation genetic testing to detect genetic disorders and rare diseases, such as fibrodysplasia ossificans progressive, is anticipated to propel the growth.
High adoption of In Vitro Fertilization (IVF) technique consequently upsurges the utilization of Preimplantation Genetic Diagnosis (PGD). These techniques are advantageous in a way that they allow the development of a healthy fetus and prevent the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.
A substantial number of patients with infertility and impaired fecundity are recommended to embrace IVF therapy in combination with PGT procedures, which in turn is expected to stimulate the growth. In addition, public and private authorities are promoting reproductive health by undertaking initiatives is also anticipated to drive the Preimplantation Genetic Testing (PGT) (PGS/PGD) market.
To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/preimplantation-genetic-testing-pgt-market
Further key findings from the report suggest:
Availability of a significant number of services related to early diagnosis of specific gene mutation in embryo marked the dominant position of PGD in 2018
Preimplantation Genetic Screening (PGS) seems to be reasonable intervention to enhance efficiency of selecting chromosomally normal embryo during IVF cycles. It is increasingly being applied for embryo screening due to ever-expanding IVF, which is projected to create lucrative growth opportunities in near future
Advancements in detection of chromosomal anomalies by executing non-invasive prenatal testing results in a maximum share of this segment in 2018
Expanding utilization rate of FISH probe sets and benefits associated with the detection of a single-gene disorder is expected to fuel the growth of X-linked diseases segment
Implementation of PGT in embryo HLA typing for stem cell therapy is expected to impose segment growth. This is further attributed to the advantages pertaining to PGS testing for identification of HLA compatible embryos during stem cell therapy
Europe accounts for largest revenue share in 2018 owing to increased usage of PGD and PGS for the delivery of genetically healthy offspring during IVF procedures
Asia Pacific market is observed to reveal the fastest CAGR due to the rise in medical tourism and the continuous development of IVF and PGD clinics in Asian countries
Key players that have commercialized PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
Key participants are actively involved in expansion of the distribution network for their products as well as R&D activities for the development of novel PGT services. In October 2018, Illumina Inc. signed an agreement with Vitrolife AB under which Vitrolife act as a distributor supplier of Illumina’s PGT products in EMEA and America.
Grand View Research has segmented the global Preimplantation Genetic Testing (PGT) (PGS/PGD) market on the basis of PGD/PGS, type, application, and region:
Preimplantation Genetic Testing (PGT) PGD/PGS Outlook (Revenue, USD Million, 2014 - 2024)
Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Screening (PGS)
Preimplantation Genetic Testing (PGT) (PGS/PGD) Type Outlook (Revenue, USD Million, 2014 - 2024)
Chromosomal Abnormalities
X-linked Diseases
Embryo Testing
Aneuploidy Screening
HLA Typing
Other PGT Types
Fresh Embryo (Own Eggs)
Frozen Embryo (Own Eggs)
Fresh Embryo (Donor Eggs)
Frozen Embryo (Donor Eggs)
Preimplantation Genetic Testing (PGT) (PGS/PGD) Application Outlook (Revenue, USD Million, 2014 - 2024)
Embryo HLA typing for stem cell therapy
IVF Prognosis
Late Onset Genetic Disorders
Inherited Genetic Disease
Others
Preimplantation Genetic Testing (PGT) (PGS/PGD) Regional Outlook (Revenue, USD Million, 2014 - 2024)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)
U.S.
Canada
Germany
U.K.
Spain
Belgium
Czech Republic
Poland
Sweden
Finland
Norway
Netherlands
Italy
Japan
China
India
Singapore
Malaysia
Brazil
Mexico
Argentina
Chile
South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
0 notes
Text
Fertility Services Market size Current Scenario, Company Profile, Growth Strategies, Trends, Scope, Challenges, Applications, Demand and Regional
Market overviewFertility services are defined as services that can help both men and women to overcome medical problems, which prevent them from having children. A new report on the global Fertility Services Market size published by Market Research Future (MRFR), observes that this market could find growth at 6.50% CAGR between 2020 and 2027.The prominent market enhancing factors for the global fertility services market include growing urbanization, rising numbers of women joining the workforce, the inclination of women for advanced studies, delayed family planning, and reimbursement schemes. Another crucial factor contributing to the market growth include advances in fertility treatment that gives women options to bear children in later years. Such technologies are gaining popularity due to use and endorsement by female celebrities. However, high costs for fertility treatments can affect market growth negatively.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6281Market SegmentationTypes of treatments include Assisted Reproductive Technology (ART) and infertility medications. The antiretroviral treatment segment is also segmented into artificial insemination, in vitro fertilization (IVF), frozen embryo replacement (FER), and others. The ART segment should be the preferred treatment for infertility due to the high success rate. In addition, the introduction of in vitro fertilization treatments, the availability of reimbursement systems that cover these options, and the patients’ disposable income may stimulate segment demand over the forecast period.Regional AnalysisEurope leads the market with the most significant share of 34.6%. Growing at a promising CAGR of 8.50%, the European markets growth can be attributed to the low fertility rate in the region as well as a trend of delayed family planning. Due to this, the regions reimbursement policies are promoting demand for fertility services.The Americas have been established as the second largest regional market. The regions well-developed healthcare system and adoption of advanced technologies have boosted fertility services in the region. Moreover, the high obesity rates in the U.S has led to a dip in fertility rates, and as a result, women are turning to fertility services, thus encouraging market growth.The APAC region is slated to grow at the fastest pace during the forecast period. Rapid urbanization in the region has resulted in changing lifestyles and the emergence of increased fertility problems. Increasingly favorable reimbursement policies and the adoption of sophisticated technology is expected to improve market growth, particularly in countries like Japan and India.Key PlayersNotable players profiled in the fertility services market report include Vitrolife (US), Ferring Pharmaceuticals Inc. (US), CARE Fertility Group Limited (UK), CooperSurgical Inc (US), Irvine Scientific (US), Cook Medical (US), and Merck KGaA (Germany). Key players have incorporated several strategies to suffice the needs of the customers and stay ahead in the competition. These strategies include partnerships, collaborations, joint ventures, recent developments, mergers and acquisitions, and innovations.LIST OF FIGURESFIGURE 1 GLOBAL FERTILITY SERVICES MARKET STRUCTURE 15FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 21FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FERTILITY SERVICES MARKET 24FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL FERTILITY SERVICES MARKET 29FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL FERTILITY SERVICES MARKET 31FIGURE 6 GLOBAL FERTILITY SERVICES MARKET, BY UNDERLYING CAUSE, 2020 & 2027 (USD MILLION) 34FIGURE 7 GLOBAL FERTILITY SERVICES MARKET, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 37FIGURE 8 GLOBAL FERTILITY SERVICES MARKET FOR ART, BY TREATMENT TYPE, 2020 & 2027 (USD MILLION) 38FIGURE 9 GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2020 & 2027 (USD MILLION) 42FIGURE 10 EUROPE: FERTILITY SERVICES MARKET SHARE, BY REGION 2020 (%) 43Browse Complete Report @
https://www.marketresearchfuture.com/reports/fertility-services-market-6281RELATED REPORTS LINK:-https://www.marketresearchfuture.com/reports/prescribed-health-apps-market-753https://www.marketresearchfuture.com/reports/venous-blood-collection-devices-market-5761https://www.marketresearchfuture.com/reports/pediatric-vaccines-market-5779About Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:Market Research FutureOffice No. 528, Amanora ChambersMagarpatta Road, Hadapsar,Pune – 411028Maharashtra, India+1 646 845 9312Email: [email protected]
0 notes
Text
Infertility Treatment Market Scope of Current and Future, Key Players Analysis by 2026
According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.
Browse in-depth TOC on "Infertility Treatment Market"
215 – Tables 40 – Figures 255 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43497112
The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years
The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112
COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete.
The fertility rate worldwide is declining steadily owing to various factors, such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment products that determine the fertility window in males and females.
The rise in number of fertility clinics to support the market growth during the forecast period.
Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112
Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally
Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.
Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others
3 notes
·
View notes
Text
Fertility Services Market 2021 future outlook of statistics on industry growth
Market Analysis and Insights: Fertility Services Market
Fertility Services Market, By Infertility (Male infertility, Female infertility), Procedure (Assisted Reproductive Technology (ART), In-Vitro Fertilization, Artificial Insemination, Surrogacy, Others), Services (Donor, Non-donor), End-User (Fertility Clinics, Hospitals, Clinical Research Institutes, Surgical Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Fertility services market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 9.20% in the above-mentioned forecast period. Rising continuous decline in fertility rates drives the fertility services market.
Download Exclusive Sample PDF at: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-residue-testing-market
Fertility services are the services taken by people who are not capable of conceiving naturally. These fertility services help single parents, LGBT community and infertile couples for procreating and to start a family. Fertility services involve several techniques which are used for treating genetic issues and infertility problems to help out in conception.
Rising delayed pregnancies in women is the vital factor escalating the market growth, also increasing technological advancements with respect to fertility treatment, increasing success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility and low sperm count in men and rise in accessibility and availability of healthcare facilities and increase in healthcare and research expenditure are the major factors among others driving the fertility services market. Moreover, rising technological advancements and modernization in the healthcare sector and rising research and development activities in the healthcare sector further create new opportunities for fertility services market in the forecasted period of 2021-2028.
However, increased treatment costs of ARTs in developed countries and rising inadequate reimbursement policies are the major factors among others which will obstruct the market growth, and will further challenge the growth of fertility services market in the forecast period mentioned above.
This global fertility services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on fertility services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Have Any Query? Ask Our Expert @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-fertility-services-market
Global Fertility Services Market Scope and Market Size
Fertility services market is segmented on the basis of infertility, procedure, services and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of infertility, the fertility services market is segmented into male infertility and female infertility.
Based on procedure, the fertility services market is segmented into assisted reproductive technology (ART) and in-vitro fertilization, artificial insemination, surrogacy and others. In-vitro fertilization has been further segmented into Intracytoplasmic sperm injection (ICSI) and pre-implantation genetic diagnostics (PGD). Artificial Insemination has been further segmented into intrauterine insemination, intracervical insemination and others.
Based on services, the fertility services market is segmented into donor and non-donor. Donor has been further segmented into fresh and frozen. Non-donor has been further segmented into fresh and frozen.
The fertility services market is also segmented on the basis of end-user into fertility clinics, hospitals, clinical research institutes and surgical centers.
Fertility Services Market Country Level Analysis
Fertility services market is analysed and market size insights and trends are provided by country, infertility, procedure, services and end-user as referenced above.
The countries covered in the fertility services market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the fertility services market due to lower fertility rate and growth in the median age of motherhood, and increasing obesity cases and increasing IVF tourism in Spain. Asia-Pacific is the expected region in terms of growth in fertility services market due to declining fertility rates in the region.
The country section of the fertility services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Request for TOC @-https://www.databridgemarketresearch.com/toc/?dbmr=global-fertility-services-market
Healthcare Infrastructure growth Installed base and New Technology Penetration
Fertility services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for fertility services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the fertility services market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Fertility Services Market Share Analysis
Fertility services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to fertility services market.
The major players covered in the fertility services market report are Olympus Corporation, Cook, The Cooper Companies Inc., Instituto Bernabeu, Virtus Health, CooperSurgical, Inc., Vitrolife, CARE Fertility, INVO Bioscience, Monash IVF, Fertility Focus, Carolinas Fertility Institute, Apollo Hospitals Enterprise Ltd., Merck KGaA, LABOTECT GMBH, Genea Limited, Medicover, The Johns Hopkins Hospital, Progyny, Inc., CryoChoice, LLC., Millendo Therapeutics, Inc., FUJIFILM Irvine Scientific, A CooperSurgical Fertility Company and IVFtech ApS. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Fertility Services Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.
Browse more related report to know about market analysis
Asia-Pacific Flexible Digital Video Cystoscopes Market
Asia-Pacific Intraoperative Imaging Market
Asia-Pacific Skin Tightening Market
Dental Diagnostic & Surgical Equipment Market
Europe Cardiac Pacemakers Market
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact: Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
In Vitro Fertilization Market worth $987 million by 2026
According to the new market research report "In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecast to 2026", published by MarketsandMarkets™, the global In Vitro Fertilization Market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026.
Browse in-depth TOC on "In Vitro Fertilization Market"
231 – Tables
39 – Figures
252 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89198891
The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options.
The in vitro fertilization (IVF) market include major Tier I and II suppliers of in vitro fertilization equipment, reagents and media are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89198891
COVID-19 has impacted their businesses as well. COVID-19 pandemic triggered the worldwide suspension of in vitro fertilization treatment; this had a profound impact on women in the 40-42 age group, resulting in 11.8% reduction in live births due to a six-month delay in IVF treatment and a 22.4% reduction due to a 12-month delay in treatment in UK. In India, 30 lakh people seek IVF every year, but only 5 lakh people undergo IVF procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who had opted for IVF treatment before the pandemic
The rise in number of IVF with ICSI procedure to support the market growth during the forecast period.
The success rate of fertilization with ICSI procedure and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period. Moreover, the growing focus of players in expanding their product offerings in ICSI is anticipated to contribute towards the rapid adoption of IVF with ICSI procedures during the forecast period.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=89198891
Asia Pacific likely to emerge as the fastest-growing in vitro fertilization market, globally.
Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 10.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the in vitro fertilization market in the region.
Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others
0 notes
Text
Preimplantation genetic testing Industry Supply Chain Analysis, Growth Opportunities, Top Companies, Revenue Growth and Business Development Report by 2026
Rising incidence single gene, mitochondrial, and other gene-related disorders, number of supportive initiatives adopted by the government authorities to promote reproductive health are key factors contributing to high CAGR of Preimplantation genetic testing during the forecast period.
the global Preimplantation genetic testing market was valued at USD 347.7 million in 2018 and is expected to reach USD 762.6 million by the year 2026, at a CAGR of 10.1%. Preimplantation Genetic testing identifies genetic defects in embryos, which are developed through Vitro Fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) is made when one or both the hereditary parents have a known hereditary disorder, and testing is performed on the embryo to determine whether it carries the same hereditary disorder. It is used is growing due to; increasing number of cases related to the predominance of genetic, hereditary and chromosomal diseases, rising knowledge amongst the population about the avoidance of genetic disorders.
A growing number of people suffering from genetic diseases are expected to increase demand for preimplantation genetic testing procedures to have a healthy child. Due to high pregnancy chances with the preimplantation genetic testing procedure as compared to other fertility treatments, the demand for PGI testing is expected to witness high demand among people seeking IVF treatments. Increasing applications for preimplantation genetic testing for the diagnosis of diseases like cancer and other minor disabilities like deafness is expected to create high growth opportunities for preimplantation genetic testing market stakeholders. Stringent government regulations related to the use of PGD have hindered the market growth of PGD market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2244
The report provides extensive coverage of the supply chain, key players of the industry, consumer base, company profiles, production and consumption rate, primary applications, and other relevant data. It provides an in-depth assessment of the key companies operating in the market along with their company profiles, business overview, production and manufacturing capacity, product portfolio, financial standing, global position, and business expansion plans. It also studies recent mergers and acquisitions, joint ventures, product launches, partnerships, collaborations, and agreements among other. The report also provides insights into new entrants and their strategic alliances to gain a robust footing in the market.
Key Manufacturers in the Global Preimplantation Genetic Testing Market:
PGT services include Natera, Inc.; CooperSurgical, Inc.; F. Hoffmann-La Roche AG; Illumina, Inc.; IGENOMIX; and others
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2244
The report also provides an extensive regional segmentation to offer the readers key insights into the spread of the market over key geographical regions. It covers production and consumption patterns, import/export, supply and demand, consumer demand and behavior, key trends, and presence of key players in each region. The report also offer a country-wise analysis to impart a better understanding of the revenue growth of the market in each region.
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, France, Rest of Europe)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Test Type (Revenue, USD Million; 2016–2026)
Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Screening (PGS)
Type (Revenue, USD Million; 2016–2026)
Fresh Embryo (Own Eggs)
Frozen Embryo (Own Eggs)
Fresh Embryo (Donor Eggs)
Frozen Embryo (Donor Eggs)
Application (Revenue, USD Million; 2016–2026)
Embryo HLA Typing for Stem Cell Therapy
IVF Prognosis
Late Onset Genetic Disorders
Inherited Genetic Disease
Others
End Use (Revenue, USD Million; 2016–2026)
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes
To know more about the report @ https://www.reportsanddata.com/report-detail/preimplantation-genetic-testing-market
Key Questions Addressed in the Report:
What is the market size the global Preimplantation Genetic Testing market is expected to reach over the forecast period? What is the expected CAGR?
What are the key segments of the market?
What are the key products and applications of the Preimplantation Genetic Testing market?
What factors are expected to drive and restrain market growth over the forecast period?
What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis?
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2244
Thank you for reading our report. The report can be customized based on regional segmentation and competitive landscape. Kindly get in touch with us to know more and our team will ensure the report is well suited to meet your requirements.
Browse more related reports:
Cardiac Safety Services Market @ https://www.medgadget.com/2020/04/cardiac-safety-services-market-to-reach-usd-895-7-million-by-2026.html
Bio Decontamination Market @ https://www.medgadget.com/2020/04/bio-decontamination-market-to-reach-usd-195-7-million-by-2026.html
Non-Invasive Fat Reduction Market @ https://www.medgadget.com/2020/04/non-invasive-fat-reduction-market-to-reach-usd-2-83-billion-by-2026.html
Liquid Embolic Market @ https://www.medgadget.com/2020/03/liquid-embolic-market-to-reach-usd-3-27-billion-by-2027.html
Therapeutic Obstructive Sleep Apnea Devices Market @ https://www.medgadget.com/2020/03/therapeutic-obstructive-sleep-apnea-devices-market-to-reach-usd-6-22-billion-by-2026.html
Surgical Navigation Systems Market @ https://www.medgadget.com/2020/03/surgical-navigation-systems-market-to-reach-usd-1-21-billion-by-2026.html
0 notes
Text
Cryopreservation for In-vitro Fertilization (IVF) Market is set to reflect an impressive 10.2% CAGR through 2030
A recent market study published by Future Market Insights (FMI) on the cryopreservation for in-vitro fertilization (IVF) market includes global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the cryopreservation for in-vitro fertilization (IVF) market, growth prospects are obtained with maximum precision.
Cryopreservation for In-vitro Fertilization (IVF) Market: Segmentation
The global cryopreservation for in-vitro fertilization (IVF) market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Product Type
Cryopreservation Media
Cryopreservation Storage Devices
Dewars
Cryogenic Liquid Cylinders
Cryogenic Storage Tanks
Storage Container
Consumables & Accessories
Cryo-Shipping
Vapor Tanks
Storage Alarm Systems
LN 2 Auto Fill Systems
LN2 Sterilization System
Cryo Control/Inventory Management Systems
Cryocanes
Visotubes
Cannisters
Vitrification Carriers
Sperm Straws
Saw Freeze Straws
Cryovials
Dry Shipper Container
Clinical Pack Over Wrap
Cryogenic Labels
Application
Oocycte Cryopreservation
Sperm Cryopreservation
Embryo Cryopreservation
End User
Biobanks
IVF & Fertility Clinics
Research & Academic Institutes
Cryo-shipping/couriers
Cryo Monitoring /Inventory Management
Regional Outlook
North America (US, Canada)
Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
Europe (Germany, UK, Russia, France, Italy, Spain, BENELUX, Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia, Rest of South Asia)
East Asia (China, Japan, and South Korea)
Oceania (Australia, New Zealand)
Middle East & Africa (GCC Countries, Turkey, South Africa, and Rest of MEA)
Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12785
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the cryopreservation for in-vitro fertilization (IVF) market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the cryopreservation for in-vitro fertilization (IVF) market.
Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the cryopreservation for in-vitro fertilization (IVF) market in this chapter, which will help them understand the basic information about the market.
Chapter 03 – Key Market Trends
This chapter highlights the key trends impacting the growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. This chapter helps reader to understand the trends of cryopreservation for in-vitro fertilization (IVF) market.
Chapter 04 – Key Success Factors
This section includes key success factors such as product adoption analysis, application road map, key promotional strategies, regulations, and many more. This section helps readers understand the key factors associated with the cryopreservation for in-vitro fertilization (IVF) market.
Chapter 05 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, and opportunity analysis that are expected to influence growth of the cryopreservation for in-vitro fertilization (IVF) market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-12785
Why Future Market Insights?
Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the In Vitro Fertilization Banking Services Market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Visit More Healthcare Reports:
Gene Editing Tools Market: Gene Editing Tools Market: Profitable Technology Transfer for CRISPR to Boost Revenues: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Venous Thromboembolism Treatment Market: Venous Thromboembolism Treatment Market: US Remains the Front Runner Driven by Favorable Reimbursement Scenario: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
Bone Growth Stimulators Market: Bone Growth Stimulators Market: Fractures & Spinal Fusion Surgeries Continue to Generate Sizeable Demand: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
0 notes
Text
Infertility Treatment Market: High procedural cost of assisted reproductive techniques in developed markets
The infertility treatment market is expected to grow from USD 1.5 billion in 2018 to USD 2.2 billion by 2023, at a compound annual growth rate (CAGR) of 8.0% during the forecast period.
Market Dynamics
Growth in the infertility treatment market is primarily driven by factors such as the declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public-private investments, funds, and grants. Growth opportunities in emerging markets and the use of fertility treatment options by single parents and same-sex couples are also expected to provide opportunities for players in this market. On the other hand, the high procedural cost of assisted reproductive techniques in developed markets and unsupportive government regulations for certain infertility treatment options are expected to limit market growth to a certain extent.
Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43497112
Driver: Declining fertility rate
Infertility is the inability of an individual to achieve clinical pregnancy. Fertility rates measure the average number of children per woman. The fertility rate worldwide is declining steadily owing to various factors such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment devices that determine the fertility window in males and females.
Restraint: High procedural cost of assisted reproductive techniques in developed markets
Along with fertility surgeries, thousands of cycles of ART procedures such as in vitro fertilization (IVF) are performed every year globally. The cost of IVF treatment varies from country to country due to lack of reimbursement policies. The average cost of one IVF cycle is USD 12,000 excluding the cost of medications; if the couple goes through three cycles, the out-of-pocket expense adds up to USD 33,000. On the other hand, the average cost of one IVF cycle in developing countries such as India ranges from USD 814.74 to USD 1,086.32, including all medications. Thus, the high cost of assisted reproductive techniques coupled with lack of insurance coverage in developed countries is restraining the growth of Infertility Treatment Devices Market.
North America is expected to hold a significant share in the infertility treatment market during the forecast period
Factors such as decreasing fertility rates, growing median age of first-time pregnancy, increase in healthcare expenditure, and presence of major players in this region (such as The Cooper Companies, Inc., Cook Group Incorporated, and Hamilton Throne Ltd.) are driving the growth of the infertility treatment market in North America.
Request a Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112
Key Market Players
The Cooper Companies Inc. (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SoMATEX Medical Technologies GmbH (Germany), among others.
Recent Developments:
· In March 2018, Vitrolife AB (Sweden) received approval for the sale of its time-lapse incubator EmbryoScope+ in the US. Through this the company expanded its product sale and market visibility in the US infertility treatment market.
· In March 2018, Genea Limited (Australia) expanded its market presence in Melbourne by establishing a new fertility clinic in Melbourne
· In April 2018, Baker Ruskinn (UK) entered into a partnership with I&L Biosystems UK Ltd. (UK) as its UK sales partner with the aim to expand its sales and distribution and strengthen its presence in the UK market
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
0 notes